A1C is a measure of your average blood sugar over the past 2–3 months, commonly included in metabolic blood panels(also written as HbA1c or HBA1C). Understanding your A1C helps assess your underlying metabolic health. A high number can signal prediabetes or even type 2 diabetes. The conversion table below shows what each A1C value translates to in mg/dL(milligrams per deciliter, the standard US unit for blood glucose). An A1C of 6.5% means your average has been about 140 mg/dL; 5.7% is roughly 117 mg/dL. But your A1C tells only part of the story — two people with the same number can have very different blood sugar patterns underneath, and a few common conditions can throw the reading off.
This guide gives you the conversion table, explains what each range means, shows where A1C falls short, and covers the lifestyle levers that actually move the number over 3 months.
How A1C is converted to average glucose
Here’s how the test works under the hood. Glucose in your blood sticks to hemoglobin (the protein in your red blood cells that carries oxygen), and the A1C test measures what percentage of hemoglobin has glucose attached. Because red blood cells live about three months, that percentage works as a built-in moving average — weighted slightly toward the last 4–6 weeks, where newer red blood cells make up a larger share.
The math behind the conversion is straightforward. Researchers paired continuous glucose monitoring with A1C in 507 subjects across 10 international centers and derived a single linear formula that converts your A1C percentage into estimated average glucose (eAG) — the same average expressed as an mg/dL number rather than as a percentage (Nathan DM et al., Diabetes Care 2008, PMID: 18540046):
eAG (mg/dL) = 28.7 × A1C − 46.7
eAG (mmol/L) = 1.59 × A1C − 2.59
You don’t need to do the math; the table below applies the formula for you.
| A1C (%) | eAG (mg/dL) | eAG (mmol/L) | Clinical range |
|---|---|---|---|
| 5.0 | 97 | 5.4 | Normal |
| 5.5 | 111 | 6.2 | Normal |
| 5.7 | 117 | 6.5 | Prediabetes (lower bound) |
| 6.0 | 126 | 7.0 | Prediabetes |
| 6.4 | 137 | 7.6 | Prediabetes (upper bound) |
| 6.5 | 140 | 7.8 | Diabetes (diagnostic threshold) |
| 7.0 | 154 | 8.6 | Diabetes — typical ADA target |
| 7.5 | 169 | 9.4 | Diabetes — above target |
| 8.0 | 183 | 10.1 | Poor glycemic control |
| 9.0 | 212 | 11.8 | Poor glycemic control |
| 10.0 | 240 | 13.4 | Severe — clinical intervention needed |
What’s a healthy A1C range?
The American Diabetes Association uses three threshold bands to interpret A1C (ADA Standards of Care 2025, Diabetes Care, PMID: 39651986):
- Normal: below 5.7% — corresponds to an average glucose under 117 mg/dL
- Prediabetes: 5.7% to 6.4% — average glucose 117–137 mg/dL. About one in three US adults sits in this range, and most do not know it (CDC National Diabetes Statistics Report).
- Diabetes: 6.5% or above — diagnosed on a single confirmed reading, paired with symptoms or a repeat test
For people already diagnosed with diabetes, the ADA Standards of Care set a general target of A1C below 7.0%, with individualized targets ranging from 6.5% (younger, healthier adults) to 8.0% (older adults with other health conditions). The target balances long-term complication risk against the risk of low blood sugar from medication.
Why your A1C might be misleading
A1C measures how much glucose is stuck to your red blood cells, not the glucose itself. So if something changes how long your red blood cells live, or how easily glucose binds to them, your A1C can move up or down without your actual blood sugar changing. Worth knowing about, because a few common conditions push A1C in misleading directions.
Conditions that can falsely lower A1C:
- Recent blood loss or hemolytic anemia (rapid red-blood-cell breakdown — newer red blood cells on average)
- Sickle cell trait or other hemoglobin variants (such as thalassemia)
- Chronic liver disease, advanced cirrhosis
- Pregnancy (especially second and third trimester)
Conditions that can falsely raise A1C:
- Iron-deficiency anemia (older red blood cells accumulate more glycation)
- B12 or folate deficiency
- Advanced chronic kidney disease
- Splenectomy (spleen removal)
There is also a population-level effect worth knowing about: racial and ethnic differences in the relationship between A1C and blood glucose have been described in multiple cohorts, with implications for diabetes screening accuracy (Herman WH, Cohen RM, J Clin Endocrinol Metab 2012, PMID: 22238408). The biological reasons are still being studied — possible factors include differences in how long red blood cells live and how easily glucose binds to hemoglobin. It is one reason continuous glucose monitoring (CGM) data is increasingly used alongside A1C rather than as a downstream check on it.
Time-in-range: the metric A1C can’t capture
A1C is just an average. It doesn’t tell you how stable or unstable your glucose actually is. Two people can have an identical A1C of 6.2% with very different day-to-day reality:
- One person sits steadily between 100 and 140 mg/dL most of the day
- The other swings between 65 mg/dL (low) and 220 mg/dL (high), averaging out to the same number
Their A1C is the same. Their metabolic exposure is not. CGM data fills that gap. The most useful single metric is Time-in-Range (TIR) — the percentage of the day your glucose actually spends between 70 and 180 mg/dL. Beck and colleagues found that every 10-percentage-point improvement in TIR maps to roughly a 0.6-percentage-point drop in A1C, on average (Beck RW et al., J Diabetes Sci Technol 2019, PMID: 30636519).
Note that the same TIR can map to different A1C values across individuals.
A second metric, the Glucose Management Indicator (GMI), estimates what your laboratory A1C would be based purely on your CGM readings (Bergenstal RM et al., Diabetes Care 2018, PMID: 30224348). GMI and laboratory A1C don’t always agree exactly — and that’s useful on its own. A meaningful gap between the two can flag the kind of A1C-distorting conditions covered above.
How to lower A1C in 3 months
Three months is not arbitrary — it is the lifespan of the red blood cells your A1C is measuring. Improvements in glucose control today will show up on your next A1C test, but most of the visible drop comes from the last 4–6 weeks before the test, not the first.
The interventions that consistently move A1C are the ones that lower after-meal glucose spikes — those spikes drive most of the glucose exposure that ends up sticking to your red blood cells.
Sequence carbohydrates last. Eating fiber, protein, and fat before the carb portion of a meal flattens the post-meal glucose curve substantially (Shukla AP et al., Diabetes Care 2015, PMID: 26106234). The effect is measurable in CGM data within a single meal.
Add a 10–15 minute walk after meals. This is the single most reliable post-meal intervention. Light walking shuttles glucose into muscle tissue before insulin has to manage it; walking specifically after meals lowers postprandial glycemia more than the same total walking spread across the day (Reynolds AN et al., Diabetologia 2016, PMID: 27747394).
Add aerobic and strength training to your week. Zone-2 cardio (the easy, conversational pace) helps your cells burn glucose more efficiently; strength training improves how well your muscles respond to insulin. Both work, and they add up.
Prioritize sleep regularity over duration. A single night of poor sleep raises fasting glucose the next morning, and chronic short sleep is associated with worse A1C in healthy adults.
Manage chronic stress. Cortisol is a glucose-raising hormone. Persistent stress (poor work-life balance, ongoing illness, chronic sleep loss) often shows up as a slowly creeping A1C even without any change in diet.
For users tracking their progress in real time, an Ultrahuman M1 CGM surfaces these changes within days rather than waiting for a quarterly lab draw — making it easier to identify which interventions actually move the dial for you.
For a deeper walkthrough of these lifestyle levers, see Ultrahuman’s how to lower A1C naturally guide.
When to test A1C
The ADA recommends:
- Twice yearly if you have diabetes and are stable / meeting glycemic goals; every 3 months if your therapy has changed or you’re not meeting goals
- Annually for adults with prediabetes (monitoring)
- Every 3 years starting at age 35 for adults without diabetes (initial screening), with frequency depending on results
Home A1C tests are widely available and have improved in accuracy, but lab tests run on certified analyzers remain the gold standard. If your home A1C result sits close to a clinical threshold, confirming with a lab draw before making lifestyle decisions is worth the extra step. CGM data, where available, is the most actionable complement — it tells you not just how high your average is, but exactly when and why it climbs.
This article is for informational purposes and is not medical advice. People with diabetes or suspected metabolic conditions should work with a clinician for diagnosis, medication, and treatment decisions. Disclosure: Ultrahuman sells the M1 CGM, Ring AIR, and Ring PRO referenced in this guide.
